Blood
WBC : 48 with 62% of eosinophils X 10 9 /l HB : 7.0g/dl Platelets : 79 X 10 9 /l Blasts : 15% Bone marrow : Normal cellularity was replaced by 60% of lymphoblasts FAB L1 morphology%.
Cyto-Pathology Classification
Immunophenotype Pre-B ALL (EGIL classification B III). The blasts expressed CD45, CD19, CD10, CD34, HLA-DR, cCD79a, cCD22, Tdt and cytoplasmic micro chain, partial CD20 and CD33 and were negative for CD2, CD7, CD13, CD15, CD117 and CD3. Diagnosis Acute lymphoblastic leukemia following a chronic eosinophilic leukemia.
Survival

Date of diagnosis: 03-2008
Treatment: Chemotherapy for ALL (12-ALLIC 02 protocol) Complete remission was obtained. Treatment related death : no Relapse : yes Phenotype at relapse During continuation phase hypereosinophilia was observed in peripheral blood, but low percentage of lymphoblasts was detected during 2-3 weeks before relapse. After this finding, the patient presented CNS infiltration by eosinophils (70% of WBC detected in CSF). He presented a bone marrow infiltration by dysplastic eosinophils and less than 5% of lymphoblasts after 18 months from achieving CR and a hematological relapse was diagnosed. Status: Death 06-2010 Survival: 21 months
